The source and role of RANTES in interstitial lung disease

European Respiratory Journal

Volumn 10, Issue 6, 1997, Pages 1207-1216

  Petrek, M ^b   Pantelidis, P ^a   Southcott, A M ^a   Lympany, P ^a   Safranek, P ^b   Black, C M ^c   Kolek, V ^d   Weigl, E ^b   Du Bois, R M ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b PALACKÝ UNIVERSITY   (Czech Republic)

^c ROYAL FREE HOSPITAL   (United Kingdom)

^d UNIVERSITY HOSPITAL OLOMOUC   (Czech Republic)

Author keywords

Chemokine RANTES; Eosinophils; Fibrosing alveolitis; Sarcoidosis; T lymphocytes

Indexed keywords

CD68 ANTIGEN; RANTES;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FIBROSING ALVEOLITIS; GENE EXPRESSION; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; INFLAMMATORY CELL; INTERSTITIAL LUNG DISEASE; LOWER RESPIRATORY TRACT; LUNG LAVAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SARCOIDOSIS;

ANTIGENS, CD45; BRONCHOALVEOLAR LAVAGE FLUID; EOSINOPHILS; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LUNG DISEASES, INTERSTITIAL; LYMPHOCYTE COUNT; LYMPHOCYTES; MACROPHAGES, ALVEOLAR; MIDDLE AGED; NEUTROPHILS; POLYMERASE CHAIN REACTION; PULMONARY FIBROSIS; RANTES; RNA, MESSENGER; SARCOIDOSIS, PULMONARY;

EID: 0030962195     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: 10.1183/09031936.97.10061207     Document Type: Article

References (33)

1. du Bois RM, Holroyd KJ, Saltini C, Crystal RG. Granulomatous processes. In: Crystal RG, West JB, eds. The Lung: Scientific Foundations. New York, Raven Press, 1991, 1925-1938.
2. Hol BEA, Hintzen RQ, Van Lier RAW, Alberts C, Out TA, Jansen HM. Soluble and cellular markers of T-cell activation in patients with pulmonary sarcoidosis. Am Rev Respir Dis 1993; 148: 643-649.
3. Allen JN, Davis WB. Eosinophilic lung diseases. Am J Respir Crit Care Med 1994; 150: 1423-1438.
4. du Bois RM. Fibrosing alveolitis. Annu Rev Med 1993; 44: 441-450.
5. Wells AU, Lorimer S, Majumdar S, et al. Fibrosing alveolitis in systemic sclerosis: increase in memory T-cells in lung interstitium. Eur Respir J 1995; 8: 266-271.
6. Schall TJ, Bacon KB. Chemokines, leukocyte trafficking, and inflammation. Curr Opinion Immunol 1994; 6: 865-873.
7. Southcott AM, Jones KP, Li D, et al. Interleukin-8 expression: differences between lone fibrosing alveolitis and fibrosing alveolitis in systemic sclerosis. Am J Respir Crit Care Med 1995; 151: 1604-1612.
8. Standiford TJ, Rolfe MW, Kunkel SL, et al. Macrophage inflammatory protein-1a expression in interstitial lung disease. J Immunol 1993; 151: 2852-2863.
9. Car BD, Meloni F, Luisetti M, Semenzato G, Gialdroni-Grassi G, Walz A. Elevated IL-8 and MCP-1 in the bronchoalveolar lavage fluid of patients with idiopathic pulmonary fibrosis and pulmonary sarcoidosis. Am J Respir Crit Care Med 1994; 149: 655-659.
10. Schall TJ, Jongstra J, Dyer BJ, et al. A human T-cell specific molecule is a member of a new gene family. J Immunol 1988; 141: 1018-1025.
11. Schall TJ, Bacon K, Toy KJ, Goeddel DV. Selective attraction of monocytes and T-lymphocytes of the memory phenotype by cytokine RANTES. Nature 1990; 347: 669-671.
12. Taub DD, Conlon K, Lloyd AR, Oppenheim JJ, Kelvin DJ. Preferential migration of activated CD4+ and CD8+ T-cells in response to MIP-1a and MIP-1b. Science 1993; 260: 355-358.
13. Alam R, Stafford S, Forsythe P, et al. RANTES is a chemotactic and activating factor for human eosinophils. J Immunol 1993; 150: 3442-3448.
14. Cordell JL, Falini B, Erber WN, et al. Immunoenzymatic labelling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal antialkaline phosphatase (APAAP complexes). J Histochem Cytochem 1984; 32: 219-229.
15. Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
16. Krug MS, Berger SL. First-strand cDNA synthesis primed with oligo(dT). Methods Enzymol 1987; 152: 316-325.
17. Corrochano LM. A test of human cDNA synthesis by the polymerase chain reaction. Genet Anal Tech Appl 1991; 8: 134-135.
18. Ponte P, Ng SY, Engel J, Gunning P, Kedes L. Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA. Nucleic Acids Res 1984; 12: 1687-1696.
19. Trapnell BC. Quantitative evaluation of gene expression in freshly isolated human respiratory epithelial cells. Am J Physiol 1993; 264 (Lung Cell Mol Physiol 8): L199-L212.
20. Heeger P, Wolf G, Meyers C, et al. Isolation and characterization of cDNA from renal tubular epithelium encoding murine RANTES. Kidney Int 1992; 41: 220-225.
21. Carré PC, Mortenson RL, King TE, Noble PW, Sable CL, Riches DWH. Increased expression of the interleukin-8 gene by alveolar macrophages in idiopathic pulmonary fibrosis: a potential mechanism for the recruitment and activation of neutrophils in lung fibrosis. J Clin Invest 1991; 88: 1802-1810.
22. Wang JH, Devalia JL, Xia CL, Sapsford RJ, Davies RJ. Expression of RANTES by human bronchial epithelial cells in vitro and in vivo and the effect of corticosteroids. Am J Respir Cell Mol Biol 1996; 14: 27-35.
23. Ying S, Taborda-Barata L, Meng Q, Humbert M, Kay AB. The kinetics of allergen-induced transcription of messenger RNA for monocyte chemotactic protein-3 and RANTES in the skin of human atopic subjects: relationship to eosinophil, T-cell, and macrophage recruitment. J Exp Med 1995; 181: 2153-2159.
24. Folkard SG, Westwick J, Millar AB. Production of IL-8 and RANTES from macrophages and monocytes of moderate asthmatic subjects. Abstracts of the IIIrd Conference on Chemokines, Bath, England, 28-30 June 1995; p.10.
25. Devergne O, Marfaing-Koka A, Schall TJ, et al. Production of the RANTES chemokine in delayed-type hypersensitivity reactions: involvement of macrophages and endothelial cells. J Exp Med 1994; 179: 1689-1694.
26. Lim KG, Wan HC, Bozza PT, et al. Human eosinophils elaborate the lymphocyte chemoattractants IL-16 (lymphocyte chemoattractant factor) and RANTES. J Immunol 1996; 156: 2566-2570.
27. Ying S, Meng Q, Taborda-Barata L, Corrigan JC, et al. Human eosinophils express messenger RNA encoding RANTES and store and release biologically active RANTES protein. Eur J Immunol 1996; 26: 70-76.
28. Wells AU, Hansell DM, Cailes J, et al. Bronchoalveolar lavage (BAL) cellularity in fibrosing alveolitis: a comparison between lone cryptogenic fibrosing alveolitis (CFA) and the fibrosing alveolitis of systemic sclerosis (FASSc). (Abstract). Eur Respir J 1995; 8: 453s
29. Kwon OJ, Kim HJ, Au BT, et al. RANTES and IL-8 were expressed in airway epithelial cells in response to tubercle bacilli stimulation. Am J Respir Crit Care Med 1996; 153: A130.
30. Robinson BWS, McLemore TL, Crystal RG. Gamma-interferon is spontaneously released by alveolar macrophages and lung T-lymphocytes in patients with pulmonary sarcoidosis. J Clin Invest 1985; 75: 1488-1495.
31. Wallace WAH, Ramage EA, Lamb D, Howie SEM. A type-2 (Th2-like) pattern of immune response predominates in the pulmonary interstitium of patients with cryptogenic fibrosing alveolitis (CFA). Clin Exp Immunol 1995; 101: 436-441.
32. Marfaing-Koka A, Devergne O, Gorgone G, et al. Regulation of the production of the RANTES chemokine by endothelial cells: synergistic induction by IFN-γ plus TNF-α and inhibition by IL-4 and IL-13. J Immunol 1995; 154: 1870-1878.
33. Hamid Q, Majumdar S, Sheppard M, et al. Expression of IL4, IL-5, IFN-γ, and IL-2 mRNA in fibrosing alveolitis associated with systemic sclerosis. Am Rev Respir Dis 1993; 147: A479.